ICH E6 (R3) Guideline on good clinical practice (GCP)
International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use
GOOD CLINICAL PRACTICE (GCP) E6(R3) Step 5
23 January 2025. Date for coming into effect 23 July 2025
ICH E6(R3) introduces innovative provisions designed to apply across various types and settings of clinical trials, ensuring continued relevance in the face of ongoing technological and methodological advancements. This guideline provides a new language to facilitate innovations in clinical trial design, technology, and operational approaches. It encourages a risk-based and proportionate approach to conducting clinical trials, promoting fit-for-purpose solutions. It fosters transparency through clinical trial registration and result reporting and offers additional guidance to enhance the informed consent process.
The overarching principles and Annex 1, adopted by ICH and CHMP, came into effect on 23 July 2025.
With the public consultation now concluded, the Annex 2 is expected to be finalised later in 2025.
I. INTRODUCTION
II. PRINCIPLES OF ICH GCP
III. ANNEX 1
1. INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)
2. INVESTIGATOR
3. SPONSOR
4. DATA GOVERNANCE – INVESTIGATOR AND SPONSOR
Appendix A. INVESTIGATOR’S BROCHURE
Appendix B. CLINICAL TRIAL PROTOCOL AND PROTOCOL AMENDMENT(S)
Appendix C. ESSENTIAL RECORDS FOR THE CONDUCT OF A CLINICAL TRIAL
GLOSSARY
© European Medicines Agency, 2025. Reproduction is authorised provided the source is acknowledged.
Official address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands
Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us
Send a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000
Clinical Research News
Upcoming Clinical Trials
-
Ningbo UniversityNot yet recruitingDepression - Major Depressive Disorder
-
The First Affiliated Hospital of Xiamen UniversityRecruiting
-
Shanghai Mental Health CenterRecruitingTreatment-resistant SchizophreniaChina
-
Nanjing First Hospital, Nanjing Medical UniversityRecruiting
-
Novo Nordisk A/SNot yet recruitingHypertension | ObesityUnited States, United Kingdom, Australia, Belgium, Poland, Denmark, Netherlands, Bulgaria, Canada, Spain, South Africa, Germany, Puerto Rico, Argentina, Brazil, Hungary, Italy, Japan, South Korea
-
University of PennsylvaniaRecruitingFirearm Safety | Firearm Safety StorageUnited States
-
Shepherd Center, Atlanta GAGeorgia Institute of TechnologyNot yet recruitingSpinal Cord InjuryUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Breast Cancer FemaleUnited States
-
Institute of Hematology & Blood Diseases Hospital...Not yet recruitingAcute Myeloid Leukemia | Measurable Residual DiseaseChina
-
AmgenRecruitingDiabetes Mellitus, Type 2United States, Canada
-
machineMD AGKantonsspital Aarau; Hôpital ophtalmique Jules-Gonin (HOJG)Not yet recruitingBinocular Vision Dysfunction
-
Second Affiliated Hospital of Nanchang UniversityNot yet recruitingObesity & OverweightChina
Clinical Research Jobs
-
Belgium - Leuven
-
United States - Reno
-
Brazil - São Paulo - São Paulo
-
Serbia - Belgrade
-
India - Bengaluru
-
United States - North Carolina - Morrisville
-
China